Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Smith

Dentist, Endodontics Birmingham, AL Doctor of Dentistry

NPI 1679662126 CMS profile 121449

1500 20Th St S, Birmingham, AL 35205

Open in the dashboard

General payments

$451,502

485 records reported · program years 2019–2025

Research payments

$100,605

Paid to them · 15 records reported · program years 2019–2025

Ownership & investment interest

$44,535

7 holdings reported · through program year 2025

Through program year 2025, James Smith of Birmingham, AL is reported in the CMS Open Payments database as having received $451,502 across 485 general payments and $100,605 in research payments paid to them. They also declared ownership or investment interests valued at $44,535 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, Endodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

15 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,561 8
2024 General $55,691 59
2023 General $52,759 60
2022 General $98,373 144
2021 General $75,767 76
2021 Research $100,605 15
2020 General $66,973 53
2019 General $97,379 85
2025 Ownership $2 1
2024 Ownership $14 1
2023 Ownership $345 1
2022 Ownership $4,650 1
2021 Ownership $9,464 1
2020 Ownership $18,540 1
2019 Ownership $11,520 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Smith
  • Dentist, Endodontics median
  • Middle half of Dentist, Endodontics
  • National median

In program year 2025, general payments to James Smith were reported at $4,561. Among 1,802 Dentist, Endodontics profiles paid that year, the median was $59 and the middle half received between $26 and $150.

Show as a table
Year James Smith Dentist, Endodontics median Middle half National median
2019 $97,379 $93 $31–$269 $163
2020 $66,973 $59 $22–$152 $114
2021 $75,767 $53 $21–$170 $132
2022 $98,373 $68 $28–$212 $149
2023 $52,759 $68 $28–$198 $160
2024 $55,691 $57 $25–$167 $164
2025 $4,561 $59 $26–$150 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sonendo Inc $451,114 482 payments
  2. A-dec, Inc. $260 2 payments
  3. NuSmile, Ltd. $129 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $281,601 115 payments
  2. Travel and Lodging $89,864 147 payments
  3. Honoraria $63,795 24 payments
  4. Food and Beverage $15,646 192 payments
  5. Gift $468 6 payments
  6. Education $128 1 payment
Products named General payments · program years 2019–2025
  1. GentleWave Console $171,369 221 payments
  2. Gentle Wave Root Canal therapy console and handpiece $164,078 135 payments
  3. GentleWave G4 Console Dental $112,418 121 payments
  4. GentleWave G4 Console Dental $3,027 1 payment
  5. Posterior CleanFlow Procedure Instrument with Matrices $208 3 payments
  6. ZARC Files $129 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sonendo Inc $100,605 15 payments

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

146

Median for Dentist: 47

Drug cost

$643

Median for Dentist: $159

Branded share of claims

34.9%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 83 $307
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 24 $155
Methylprednisolone Generic 12 $110
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 27 $71

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

500 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record